Sartorius Stedim Biotech Stock OTC Markets

Equities

SDMHF

FR0013154002

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 14:46:14 2024-07-09 EDT 5-day change 1st Jan Change
176.2 USD +0.69% Intraday chart for Sartorius Stedim Biotech 0.00% -33.19%

Financials

Sales 2024 * 2.9B 3.17B 4.33B Sales 2025 * 3.25B 3.55B 4.86B Capitalization 16.87B 18.44B 25.22B
Net income 2024 * 302M 330M 451M Net income 2025 * 417M 456M 623M EV / Sales 2024 * 6.61 x
Net Debt 2024 * 2.27B 2.48B 3.39B Net Debt 2025 * 2.17B 2.37B 3.24B EV / Sales 2025 * 5.86 x
P/E ratio 2024 *
52.3 x
P/E ratio 2025 *
37.2 x
Employees 10,493
Yield 2024 *
0.42%
Yield 2025 *
0.52%
Free-Float 31.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.69%
Current month+6.79%
1 month-7.26%
3 months-34.74%
6 months-27.19%
Current year-33.19%
More quotes
1 month
158.00
Extreme 158
176.20
Current year
158.00
Extreme 158
299.86
1 year
158.00
Extreme 158
321.11
3 years
158.00
Extreme 158
653.00
5 years
135.55
Extreme 135.55
653.00
10 years
60.06
Extreme 60.06
653.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 19-03-25
Chairman 59 07-06-28
Chief Tech/Sci/R&D Officer 59 09-04-28
Members of the board TitleAgeSince
Director/Board Member 62 07-06-28
Chairman 59 07-06-28
Director/Board Member 67 15-04-06
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, July 09, 2024 at 02:46 pm

More quotes
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
173.4 EUR
Average target price
237.3 EUR
Spread / Average Target
+36.91%
Consensus